文献
J-GLOBAL ID:201802233373349829
整理番号:18A1429351
転移性前立腺癌におけるゲノム特徴と構造変異【JST・京大機械翻訳】
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
著者 (90件):
Quigley David A.
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA)
,
Quigley David A.
(Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA)
,
Dang Ha X.
(McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA)
,
Dang Ha X.
(Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA)
,
Zhao Shuang G.
(Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA)
,
Lloyd Paul
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Aggarwal Rahul
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Alumkal Joshi J.
(Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA)
,
Alumkal Joshi J.
(Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA)
,
Foye Adam
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Kothari Vishal
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Perry Marc D.
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Bailey Adina M.
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Playdle Denise
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Barnard Travis J.
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Zhang Li
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Zhang Jin
(Cancer Biology Division, Department of Radiation Oncology, Washington University in St. Louis, MO USA)
,
Zhang Jin
(Institute for Informatics (I2), Washington University in St. Louis, MO)
,
Youngren Jack F.
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Cieslik Marcin P.
(Department of Pathology, University of Michigan, Ann Arbor, MI, USA)
,
Cieslik Marcin P.
(Michigan Center for Translational Pathology, Ann Arbor, MI, USA)
,
Parolia Abhijit
(Department of Pathology, University of Michigan, Ann Arbor, MI, USA)
,
Parolia Abhijit
(Michigan Center for Translational Pathology, Ann Arbor, MI, USA)
,
Beer Tomasz M.
(Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA)
,
Thomas George
(Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA)
,
Thomas George
(Department of Pathology, Oregon Health and Science University, Portland, OR, USA)
,
Chi Kim N.
(Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada)
,
Chi Kim N.
(British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada)
,
Gleave Martin
(Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada)
,
Lack Nathan A.
(Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada)
,
Zoubeidi Amina
(Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada)
,
Reiter Robert E.
(Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA)
,
Reiter Robert E.
(VA Greater Los Angeles Healthcare System, Department of Medicine, Los Angeles, CA, USA)
,
Rettig Matthew B.
(Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA)
,
Witte Owen
(Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA)
,
Ryan Charles J.
(Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA)
,
Fong Lawrence
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Kim Won
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Friedlander Terence
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Chou Jonathan
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Li Haolong
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Das Rajdeep
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Li Hui
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Moussavi-Baygi Ruhollah
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Goodarzi Hani
(Department of Biophysics and Biochemistry, UCSF, San Francisco, CA, USA)
,
Goodarzi Hani
(Department of Urology, UCSF, San Francisco, CA, USA)
,
Gilbert Luke A.
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA)
,
Gilbert Luke A.
(Department of Urology, UCSF, San Francisco, CA, USA)
,
Lara Primo N.
(Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA)
,
Lara Primo N.
(Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA)
,
Evans Christopher P.
(Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA)
,
Evans Christopher P.
(Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA)
,
Goldstein Theodore C.
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Goldstein Theodore C.
(UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA)
,
Stuart Joshua M.
(UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA)
,
Tomlins Scott A.
(Department of Pathology, University of Michigan, Ann Arbor, MI, USA)
,
Tomlins Scott A.
(Department of Urology, University of Michigan, Ann Arbor, MI, USA)
,
Spratt Daniel E.
(Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA)
,
Cheetham R. Keira
(Illumina, Inc., San Diego, CA, USA)
,
Cheng Donavan T.
(Illumina, Inc., San Diego, CA, USA)
,
Farh Kyle
(Illumina, Inc., San Diego, CA, USA)
,
Gehring Julian S.
(Illumina, Inc., San Diego, CA, USA)
,
Hakenberg Jorg
(Illumina, Inc., San Diego, CA, USA)
,
Liao Arnold
(Illumina, Inc., San Diego, CA, USA)
,
Febbo Philip G.
(Illumina, Inc., San Diego, CA, USA)
,
Shon John
(Illumina, Inc., San Diego, CA, USA)
,
Sickler Brad
(Illumina, Inc., San Diego, CA, USA)
,
Batzoglou Serafim
(Illumina, Inc., San Diego, CA, USA)
,
Knudsen Karen E.
(Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA)
,
He Housheng H.
(Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada)
,
Huang Jiaoti
(Department of Pathology, Duke University, Durham, NC, USA)
,
Wyatt Alexander W.
(Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada)
,
Dehm Scott M.
(Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA)
,
Dehm Scott M.
(Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA)
,
Ashworth Alan
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA)
,
Ashworth Alan
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Chinnaiyan Arul M.
(Department of Pathology, University of Michigan, Ann Arbor, MI, USA)
,
Chinnaiyan Arul M.
(Michigan Center for Translational Pathology, Ann Arbor, MI, USA)
,
Chinnaiyan Arul M.
(Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA)
,
Chinnaiyan Arul M.
(Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USA)
,
Chinnaiyan Arul M.
(Department of Urology, University of Michigan, Ann Arbor, MI, USA)
,
Chinnaiyan Arul M.
(Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA)
,
Maher Christopher A.
(McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA)
,
Maher Christopher A.
(Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA)
,
Small Eric J.
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA)
,
Small Eric J.
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Feng Felix Y.
(Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA)
,
Feng Felix Y.
(Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA)
,
Feng Felix Y.
(Department of Radiation Oncology, UCSF, San Francisco, CA, USA)
,
Feng Felix Y.
(Department of Urology, UCSF, San Francisco, CA, USA)
資料名:
Cell (Cambridge, Mass.)
(Cell (Cambridge, Mass.))
巻:
174
号:
3
ページ:
758-769.e9
発行年:
2018年
JST資料番号:
A0707B
ISSN:
0092-8674
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)